Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Coagulation Cascade in IPF
NCT02885961Unknown
- Sponsor
- University College London
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of dabigatran in idiopathic pulmonary fibrosis (IPF), sponsored by University College London. Primary endpoint: Change in FDG avidity at 4 weeks. Status: unknown.
02
Drugs
dabigatran
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02885961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02885961.